Mabion

Trending Articles

  1. PCI Pharma Services appoints Business Development Manager Jens Peter Nielsen joins the outsourcing firm's European packaging team
  2. Oxford BioTherapeutics signs T-cell engager collaboration with Bristol Myers Squibb for solid tumour targets The company has entered a multi-year collaboration with BMS to discover and develop next-generation T-cell engager therapies for solid tumours using its OGAP-Verify platform,...
  3. An integrated path: how CDMOs are reshaping complex drug development The pharmaceutical CDMO sector is rapidly evolving toward integrated, end-to-end partnerships that align development, manufacturing, packaging and supply to meet the growing...
  4. Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure
  5. Ofichem consolidates six brands into single integrated CDMO and pharmaceutical supplier identity Dutch family-owned pharmaceutical company Ofichem has unified its six business units — spanning API, drug substance, drug product and distribution — under a single trading...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The evolution of the CDMO model in Central Europe: strategic partnerships as a catalyst for change

As the Central European outsourcing market matures, companies such as Mabion are redefining the CDMO paradigm with integrated biologics expertise and long-term codevelopment partnerships that elevate the region from cost-efficient manufacturer to strategic biopharma collaborator
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part II)

Industry leaders at CPHI Frankfurt are embracing emerging technologies — including automation, AI, advanced analytics and innovative manufacturing platforms — to drive efficiency, quality, scalability and sustainability in pharmaceutical production and development
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part I)

Discover how emerging technologies and expert insights are shaping the future of pharma manufacturing
Manufacturing

Mabion tapped as CDMO of choice for manufacture of NovalGen's T-cell engager

Mabion will now be responsible for the clinical trial manufacture of the blood cancer and solid tumour-focused therapeutic candidate
Manufacturing

Mabion launches €500k oncology services contest at Bio International

The competition is designed to help biotechs scale and commercialise their recombinant protein-based oncology therapeutics
You need to be a subscriber to read this article.
Click here to find out more.
Distribution

DCAT preview: the future of pharma manufacturing

Ahead of the upcoming trade show, Dr Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond
Subscribe now